26.03 - Ndays 2025 _ Brochure_Clinical_Cases - Flipbook - Page 121
CLINICAL CASE
PEG as a safe alternative after
BDDE-related delayed
Dr. Cosmina Sandor
inflammatory reaction:
a case report
Dermatologist,
Romania
REPORT SUMMARY
PATIENT
A patient with prior delayed
inflammatory reaction to BDDE-based
fillers requested HA treatment three years
after resolution.
TREATMENTS
Neauvia Stimulate (PEG-crosslinked HA 26
mg/ml + 1% CaHA) was chosen for safety
and dual volumizing/biostimulatory
action.
BEFORE
RESULTS
A total of 2 ml was injected bilaterally
into the lateral and mid-to-lower face
using linear retrograde and fanning
techniques. At 12-month follow-up,
volume and skin quality were restored
with no inflammatory recurrence.
AFTER
FILLERS
STIMULATE
Neauvia products are for trained experts only. Use must follow approved indications and the Instructions for Use (IFU) in accordance to
applicable laws and regulations in each country. Physicians are solely responsible for any treatments outside these conditions. The results
shown are specific to an individual treatment plan. Treatment decisions must be adapted to each patient, who may respond differently
based on numerous factors. Outcomes are variable and not guaranteed.
119
